Hero Banner

ACTIVITY TITLE

Breaking Through Inertia: How to Initiate and Maintain Insulin Therapy in Patients with Type 2 Diabetes.

EDUCATIONAL GRANT SUPPORT

This satellite symposium is supported by an educational grant from Novo Nordisk.

ACTIVITY DATE

October 28, 2023 at the Marriott Marquis Chicago, Chicago IL.

TARGET AUDIENCE

The educational design of this activity addresses the needs of US-based healthcare professionals, including primary care physicians and family physicians.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

  • Identify patients with T2DM who are likely to benefit from insulin therapy based on current guidelines, evidence, and treatment goals
  • Review the efficacy and safety of different insulin options for T2DM
  • Summarize the rationale, efficacy and safety of emerging longer-acting basal insulins for T2DM management
  • Develop individualized treatment regimens for patients with T2DM that include the initiation and maintenance of insulin therapy based on current guidelines and patient-specific considerations

JOINT PROVIDERSHIP STATEMENT

Jointly20Accredited20Provider20TM
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION

PACE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed Credit

The AAFP has reviewed Breaking Through Inertia: How To Initiate and Maintain Insulin Therapy in Patients with Type 2 Diabetes and deemed it acceptable for up to 1.50 Live AAFP Prescribed credits. Term of Approval is from 10/28/2023 to 10/28/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. 

FEE INFORMATION & REFUND/CANCELLATION POLICY

Registration to this event is complimentary, however you must be a registered attendee of the 2023 AAFP FMX. This event is not a part of the official AAFP FMX.

HOW TO REQUEST CE CREDIT

An evaluation link will be emailed to all attendees after the symposium. Upon completion of the CME/CE evaluation, you will be able to print your certificate.

Several email reminders will be sent post-meeting. Please claim your credits by completing the evaluation by Monday, November 6, 2023.

DISCLOSURES

Information on planner and faculty disclosures will be posted before the meeting.

DISCLOSURE OF CONFLICT OF INTEREST

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.